Results 121 to 130 of about 25,335 (131)

A comprehensive, population level evaluation of previously reported drug triggers of pemphigus highlights immunomodulatory capacity as a common characteristic. [PDF]

Front Immunol
Baroukhian J, Seiffert-Sinha K, Sinha AA.   +2 more
europepmc   +1 more source

Long-term effectiveness and safety of methotrexate-tacrolimus combination therapy versus methotrexate monotherapy in reducing rheumatoid arthritis flares after TNF inhibitor discontinuation: a retrospective cohort study. [PDF]

BMC Rheumatol
Naniwa T, Kajiura M.
europepmc   +1 more source

Case Report: A refractory unusual tetrad of overlap syndrome involving rheumatoid arthritis, Sjögren's syndrome, autoimmune hepatitis, and type 1 renal tubular acidosis, successfully treated with a BLyS/APRIL dual inhibitor. [PDF]

Front Immunol
Wang W, Ma X, Zhang B, Zhang Z, Wu X, Jiang H, Shi X.   +6 more
europepmc   +1 more source

Efficacy and safety of tofacitinib in rheumatoid arthritis: Nine years of real-world data. [PDF]

Clin Transl Sci
Ekin A, Misirci S, İldemir S, Coskun BN, Yagiz B, Dalkilic E, Pehlivan Y.   +6 more
europepmc   +1 more source

Obesity and fibromyalgia are associated with Difficult-to-Treat Rheumatoid Arthritis (D2T-RA) independent of age and gender. [PDF]

Arthritis Res Ther
Luciano N, Barone E, Brunetta E, D'Isanto A, De Santis M, Ceribelli A, Caprioli M, Guidelli GM, Renna D, Selmi C.   +9 more
europepmc   +1 more source

Diagnosis of B-cell lymphoproliferative disorder through concomitant management of medication-related osteonecrosis of the jaw: A case report [PDF]

, 2019
Buckley, James G., Champion, Allen F., Diecidue, Robert, Zhou, Ruifeng   +3 more
core   +1 more source

Safety of Janus kinase inhibitors in rheumatoid arthritis: a disproportionality analysis using FAERS database from 2012 to 2022. [PDF]

Clin Rheumatol
Mikaeili B, Alqahtani ZA, Hincapie AL, Guo JJ.   +3 more
europepmc   +1 more source

Myeloablative autologous stem-cell transplantation for severe scleroderma [PDF]

, 2018
Brasington, R., et al,
core   +1 more source

Biological Agents' Adverse Events in Jordanian Childhood Rheumatic Diseases: A Single-Center Experience. [PDF]

Cureus
Alsuweiti MO, Alma'aitah HQ, Alnsour HM, Alwraikat BA, Alzyoud AI, Nobani M, Alzyoud RM.   +6 more
europepmc   +1 more source

Difficult-to-treat axial spondyloarthritis patients. [PDF]

Arch Rheumatol
Saygın Öğüt T, Erbasan F, Şahiner MF, Nokay M, Yörük Öğüt A, Dilbil M, Terzioğlu ME, Yazısız V.   +7 more
europepmc   +1 more source